View Document Preview and Link Open Document Share Result on Facebook
City Newark / / Company Klemens S. P. / Wellcome Trust / R. T. Sa / D. R. Nash L. C. / R. S. S. A. / / Currency USD / / / Facility Robert S. Wallis* University of Medicine / / / IndustryTerm treatment of leprosy / / MedicalCondition intracellular Mycobacterium tuberculosis H37Rv / M. tuberculosis H37Rv / TB / M. tuberculosis / Intracellular Mycobacterium tuberculosis / pulmonary tuberculosis / Mycobacterium tuberculosis / MDR TB / virulent Mycobacterium tuberculosis H37Rv / virulent Mycobacterium tuberculosis / infection / leprosy / intracellular virulent Mycobacterium tuberculosis / multidrug-resistant tuberculosis / tuberculosis / intracellular M. tuberculosis / / MedicalTreatment vaccination / chemotherapy / / Organization Department of Medicine / Institutional Review Board / American Society for Microbiology / University of Medicine and Dentistry of New Jersey / New Jersey Medical School / / Person J. Barker / Jerrold Ellner / Robert S. Wallis Antimicrob / Robert S. Wallis / Carolina Sofer / Jack DeHovitz / C. Carroll / W. Hellmann / G. Kaplan / Kusner / Ho-Yeon Song / Z. A. Cohn / / / Position investigator / D. J. / Corresponding author / / Product Kanamycin / pyrazinamide / amoxicillin / isoniazid / rifampin / / ProvinceOrState New Jersey / / PublishedMedium ANTIMICROBIAL AGENTS AND CHEMOTHERAPY / / Technology CHEMOTHERAPY / Institutional Review Board-approved protocol / http / apoptosis / / URL http / SocialTag 
Untitled